Speaker

Brent Meadows

Chief Business Officer, Senovia Biosciences

Brent Meadows, Chief Business Officer, Senovia Biosciences, is speaking at 2nd Obesity & Weight Loss Drug Development Summit Europe (Munich, Germany, 28–29 Oct 2026) in the session “Unlocking the Potential of Ketosis to Enhance Effective, Maintainable Weight Loss”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Obesity & Weight Loss Drug Development Summit Europe
28–29 Oct 2026Munich, Germany
- SpeakerUnlocking the Potential of Ketosis to Enhance Effective, Maintainable Weight Loss
- PanelPanel Discussion: Evaluating Opportunities to Improve Long-Term Weight Loss ManagementWith Xavier Jacq, Steffen-Sebastian Bolz

More speakers at 2nd Obesity & Weight Loss Drug Development Summit Europe

Anna Altieri
Translational Research Associate, Resalis Therapeutics
Henrik Bjork Hansen
Director - Scientific, Gubra
Martin Brenner
Chief Executive & Scientific Officer, iBio
Daniel de la Torre
VP of Research & Development, Constructive Bio
Mélanie Flaender
Head of Project Management, Cytoo
Lora Heisler
Professor, University of Aberdeen

See all 17 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Brent Meadows, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].